BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Fish and Richardson
Cantor Fitzgerald
Farmers Insurance

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,023,082

« Back to Dashboard

Summary for Patent: 5,023,082

Title: Sustained-release pharmaceutical compositions
Abstract:The present invention pertains to biodegradable sustained-release composins capable of achieving the sustained release of a pharmaceutical or other agent. The compositions can be formed into implant devices which may be used to treat a wide variety of diseases and conditions. The implants are especially useful in treating diseases such as periodontal disease which require prolonged drug release.
Inventor(s): Friedman; Michael (Jerusalem, IL), Steinberg; Doron (Jerusalem, IL), Soskolne; Aubrey (Jerusalem, IL)
Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem (Jerusalem, IL)
Application Number:07/175,623
Patent Claim Types:
see list of patent claims
Composition; Use; Device;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,023,082

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Israel78826May 18, 1986

International Patent Family for Patent: 5,023,082

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria80996► Subscribe
Australia605487► Subscribe
Australia7480687► Subscribe
Canada1307463► Subscribe
Germany3781928► Subscribe
Denmark175590► Subscribe
Denmark20488► Subscribe
European Patent Office0246809► Subscribe
Spain2044925► Subscribe
Greece3006681► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Federal Trade Commission
US Army
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus